Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DOVE S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pohlki, F; Dove, S
      The mechanism of the [Cp2TiMe2]-catalyzed intermolecular hydroamination ofalkynes

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    2. Dutcher, JD; Worley, RE; Conner, P; Dove, S
      Pecan varietal differences in hemipteran kernel damage

      JOURNAL OF ENTOMOLOGICAL SCIENCE
    3. Kelley, MT; Burckstummer, T; Wenzel-Seifert, K; Dove, S; Buschauer, A; Seifert, R
      Distinct interaction of human and guinea pig histamine H-2-receptor with guanidine-type agonists

      MOLECULAR PHARMACOLOGY
    4. Mayer, A; Scheglmann, D; Dove, S; Glatz, A; Wickner, W; Haas, A
      Phosphatidylinositol 4,5-bisphosphate regulates two steps of homotypic vacuole fusion

      MOLECULAR BIOLOGY OF THE CELL
    5. Aiglstorfer, I; Hendrich, I; Moser, C; Bernhardt, G; Dove, S; Buschauer, A
      Structure-activity relationships of neuropeptide YY1 receptor antagonists related to BIBP 3226

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. Dove, S; Michel, MC; Knieps, S; Buschauer, A
      Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide YY1 receptor antagonists

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    7. Dove, S; Buschauer, A
      Improved alignment by weighted field fit in CoMFA of histamine H-2 receptor agonists imidazolylpropylguanidines

      QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS
    8. Mahboobi, S; Dove, S; Kuhr, S; Pongratz, H
      Synthesis of arcyriarubine regioisomers by Pd(0)-catalysis or via lithiated indole derivatives - conformational analysis by semiempirical and X-ray methods

      PHARMAZIE
    9. Mahboobi, S; Burgemeister, T; Dove, S; Kuhr, S; Popp, A
      Homoarcyriaflavin: Synthesis of ring-expanded arcyriaflavin analogues

      JOURNAL OF ORGANIC CHEMISTRY
    10. MAYER KK; DOVE S; PONGRATZ H; ERTAN M; WIEGREBE W
      ELECTRON-IMPACT INDUCED FRAGMENTATION OF YL-4,6,7,8-TETRAHYDRO-1H,3H-QUINAZOLINE-2,5-DIONES

      Heterocycles
    11. AIGLSTORFER I; UFFRECHT A; GESSELE K; MOSER C; SCHUSTER A; MERZ S; MALAWSKA B; BERNHARDT G; DOVE S; BUSCHAUER A
      NPY Y-1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS OF ARGININE DERIVATIVES AND HYBRID COMPOUNDS WITH ARPROMIDINE-LIKE PARTIAL STRUCTURES

      Regulatory peptides
    12. TURNER RC; HOLMAN RR; CULL CA; STRATTON IM; MATTHEWS DR; FRIGHI V; MANLEY SE; NEIL A; MCELROY K; WRIGHT D; KOHNER E; FOX C; HADDEN D; MEHTA Z; SMITH A; NUGENT Z; PETO R; ADLEL AI; MANN JI; BASSETT PA; OAKES SF; DORNAN TL; ALDINGTON S; LIPINSKI H; COLLUM R; HARRISON K; MACINTYRE C; SKINNER S; MORTEMORE A; NELSON D; COCKLEY S; LEVIEN S; BODSWORTH L; WILLOX R; BIGGS T; DOVE S; BEATTIE E; GRADWELL M; STAPLES S; LAM R; TAYLOR F; LEUNG L; CARTER RD; BROWNLEE SM; FISHER KE; ISLAM K; JELFS R; WILLIAMS PA; WILLIAMS FA; SUTTON PJ; AYRES A; LOGIE LJ; LOVATT C; EVANS MA; STOWELL LA; ROSS I; KENNEDY IA; CROFT D; KEEN AH; ROSE C; RAIKOU M; FLETCHER AE; BULPITT C; BATTERSBY C; YUDKIN JS; STEVENS R; STEARN MR; PALMER SL; HAMMERSLEY MS; FRANKLIN SL; SPIVEY RS; LEVY JC; TIDY CR; BELL NJ; STEEMSON J; BARROW BA; COSTER R; WARING K; NOLAN L; TRUSCOTT E; WALRAVENS N; COOK L; LAMPARD H; MERLE C; PARKER P; MCVITTIE J; DRAISEY I; MURCHISON LE; BRUNT AHE; WILLIAMS MJ; PEARSON DW; PETRIE XMP; LEAN MEJ; WALMSLEY D; LYALL F; CHRISTIE E; CHURCH J; THOMSON E; FARROW A; STOWERS JM; STOWERS M; MCHARDY K; PATTERSON N; WRIGHT AD; LEVI NA; SHEARER ACI; THOMPSON RJW; TAYLOR G; RAYTON S; BRADBURY M; GLOVER A; SMYTHOSBOURNE A; PARKES C; GRAHAM J; ENGLAND P; GYDE S; EAGLE C; CHAKRABARTI B; SMITH J; SHERWELL J; OAKLEY NW; WHITEHEAD MA; HOLLIER GP; PILKINGTON T; SIMPSON J; ANDERSON M; MARTIN S; KEAN J; RICE B; ROLLAND A; NISBET J; KOHNER EM; DORNHORST A; DODDRIDGE MC; DUMSKYIJ M; WALJI S; SHARP P; SLEIGHTHOLM M; VANTERPOOL G; FROST G; ROSEBLADE M; ELLIOTT S; FORRESTER S; FOSTER M; MYERS K; CHAPMAN R; HAYES JR; HENRY RW; FEATHERSTON MS; ARCHBOLD GPR; COPELAND M; HARPER R; RICHARDSON I; DAVISON HA; ALEXANDER L; SCARPELLO JHB; SHIERS DE; TUCKER RJ; WORTHINGTON JRH; ANGRIS S; BATES A; WALTON J; TEASDALE M; BROWNE J; STANLEY S; DAVIS BA; STRANGE RC; HADDEN DR; KENNEDY L; ATKINSON AB; BELL PM; MCCANCE DR; RUTHERFORD J; CULBERT AM; HEGAN C; TENNET H; WEBB N; ROBINSON I; HOLMES J; NESBITT S; SPATHIS AS; HYER S; NANSON ME; JAMES LM; TYRELL JM; DAVIS C; STRUGNELL P; BOOTH M; PETRIE H; CLARK D; HULLAND S; BARRON JL; GOULD BC; SINGER J; BADENOCH A; MCGREGOR M; ISENBERG L; ECKERT M; ALIBHAI K; MARRIOT E; COX C; PRICE R; FERNANDEZ M; RYLE A; CLARKE S; WALLACE G; MEHMED E; LANKESTER JA; HOWARD E; WAITE A; MACFARLANE S; GREENWOOD RH; WILSON J; DENHOLM MJ; TEMPLE RC; WHITFIELD K; JOHNSON F; MUNROE C; GORICK S; DUCKWORTH E; FATMAN M; RAINBOW S; BORTHWICK L; WHEATCROFT DJ; SEAMAN RJ; CHRISTIE RA; WHEATCROFT W; MUSK P; WHITE J; MCDOUGAL S; BOND M; RANIGA P; DAY JL; DOSHI MJ; WILSON JG; HOWARDWILLIAMS JR; HUMPHREYS H; GRAHAM A; HICKS K; HEXMAN S; BAYLISS P; PLEDGER D; NEWTON RW; JUNG RT; ROXBURGH C; KILGALLON B; DICK L; WAUGH N; KILBY S; ELLINGFORD A; BURNS J; FOX CV; HOLLOWAY MC; COGHILL HM; HEIN N; FOX A; COWAN W; RICHARD M; QUESTED K; EVANS SJ; PAISEY RB; BROWN NPR; TUCKER AJ; PAISEY R; GARRETT F; HOGG J; PARK P; WILLIAMS K; HARVEY P; WILCOCKS R; MASON S; FROST J; WARREN C; ROCKET P; BOWER L; ROLAND JM; BROWN DJ; YOUENS J; STANTONKING K; MUNGALL H; BALL V; MADDISON W; DONNELLY D; KING S; GRIFFIN P; SMITH S; CHURCH S; DUNN G; WILSON A; PALMER K; BROWN PM; HUMPHRISS D; DAVIDSON AJM; ROSE R; ARMISTEAD L; TOWNSEND S; POON P; PEACOCK IDA; CULVERWELL NJC; CHARLTON MH; CONNOLLY BPS; PEACOCK J; BARRETT J; WAIN J; BEESTON W; KING G; HILL PG; BOULTON AJM; ROBERTSON AM; KATOULIS V; OLUKOGA A; MCDONALD H; KUMAR S; ABOUAESHA F; ABUAISHA B; KNOWLES EA; HIGGINS S; BOOKER J; SUNTER J; BREISLIN K; PARKER R; RAVAL P; CURWELL J; DAVENPORT H; SHAWCROSS G; PREST A; GREY J; COLE H; SEREVIRATNE C; YOUNG RJ; CLYNE JR; GIBSON M; OCONNELL I; WONG LM; WILSON SJ; WRIGHT KL; WALLACE C; MCDOWELL D; BURDEN AC; SELLEN EM; GREGORY R; ROSHAN M; VAGHELA N; BURDEN M; SHERRIFF C; MANSINGH S; CLARKE J; GRENFELL J; TOOKE JE; MACLEOD K; SEAMARK C; RAMMELL M; PYM C; STOCKMAN J; YEO C; PIPER J; LEIGHTON L; GREEN E; HOYLE M; JONES K; HUDSON A; JAMES AJ; SHORE A; HIGHAM A; MARTIN B; NEIL HAW; BUTTERFIELD WJH; DOLL WRS; EASTMAN R; FERRIS FR; KURINIJ N; MCPHERSON K; MAHLER RF; MEADE TW; SHAFER G; WATKINS PJ; KEEN H; SIEGEL D; WRIGHT AD; BETTERIDGE DJ; COHEN RD; CURRIE D; DARBYSHIRE J; FORRESTER JV; GUPPY T; JOHNSTON DG; MCGUIRE A; MURPHY M; ELNAHAS AM; PENTECOST B; SPIEGELHALTER D; ALBERTI KGMM; DENTON R; HOME PD; HOWELL S; JARRETT JR; MARKS V; MARMOT M; WARD JD
      INTENSIVE BLOOD-GLUCOSE CONTROL WITH SULFONYLUREAS OR INSULIN COMPARED WITH CONVENTIONAL TREATMENT AND RISK OF COMPLICATIONS IN PATIENTS WITH TYPE-2 DIABETES (UKPDS-33)

      Lancet
    13. DOVE S; BUSCHAUER A
      QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS AND POSSIBLE RECEPTOR-BINDING OF HISTAMINE H-2 AGONISTIC IMIDAZOLYLPROPYLGUANIDINES

      Naunyn-Schmiedeberg's archives of pharmacology
    14. DOVE S; BUSCHAUER A
      QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS AND POSSIBLE RECEPTOR-BINDING OF HISTAMINE H-2 AGONISTIC IMIDAZOLYLPROPYLGUANIDINES

      Naunyn-Schmiedeberg's archives of pharmacology
    15. DOVE S; BUSCHAUER A
      STEPWISE LEAVE-ONE-ISOMER-OUT FREE-WILSON APPROACHES AS PREPROCESSINGTOOLS IN QSAR ANALYSIS OF RACEMATES

      Quantitative structure-activity relationships
    16. MULLER M; KNIEPS S; GESSELE K; DOVE S; BERNHARDT G; BUSCHAUER A
      SYNTHESIS AND NEUROPEPTIDE-Y Y-1 RECEPTOR ANTAGONISTIC ACTIVITY OF N,N-DISUBSTITUTED OMEGA-GUANIDINOIC AND OMEGA-AMINOALKIANOIC ACID-AMIDES

      Archiv der pharmazie
    17. MAHBOOBI S; DOVE S; BEDNARSKI PJ; KUHR S; BURGEMEISTER T; SCHOLLMEYER D
      X-RAY CRYSTAL-STRUCTURE OF WOODININE AND CONFORMATIONAL-ANALYSIS BY SEMIEMPIRICAL AND H-1-NMR METHODS

      Journal of natural products
    18. MARKL G; STIEGLER J; KREITMEIER P; BURGEMEISTER T; KASTNER F; DOVE S
      CONFIGURATIONAL AND CONFORMATIONAL ISOMER IC ANTIAROMATIC [28]TETRAOXAPORPHYRINOIDS(4.2.4.2) AND AROMATIC [26]TETRAOXAPORPHYRIN(4.2.4.2) DICATIONS - A NEW-TYPE OF MOLECULAR-DYNAMICS IN MACROCYCLIC SYSTEMS

      Helvetica Chimica Acta
    19. KNIEPS S; MICHEL MC; DOVE S; BUSCHAUER A
      NONPEPTIDE NEUROPEPTIDE-Y ANTAGONISTS FROM THE HISTAMINE H-2 AGONIST ARPROMEDINE - ROLE OF THE GUANIDINE GROUP

      Bioorganic & medicinal chemistry letters
    20. MOKROZ MJ; STREKOWSKI L; KOZAK WX; DUSZYNSKA B; BOJARSKI AJ; KLODZINSKA A; CZARNY A; CEGLA MT; DERENWESOLEK A; CHOHNACKAWOJCIK E; DOVE S; MOKROSZ JL
      6-DI(HETEROARYL)-2-(N-METHYLPIPERAZINO)PYRIMIDINES AS NEW, POTENT 5-HT2A RECEPTOR LIGANDS - A VERIFICATION OF THE TOPOGRAPHIC MODEL

      Archiv der pharmazie
    21. DOVE S; SCHONENBERGER H
      COMPUTER MODELING OF ESTROGENIC TRANSCRIPTIONAL ACTIVATION CAN ACCOUNT FOR DIFFERENT TYPES OF DOSE-RESPONSE CURVES OF ESTROGENS

      Journal of steroid biochemistry and molecular biology
    22. DOVE S; HORWITZ J; MCFALLNGAI M
      A BIOCHEMICAL-CHARACTERIZATION OF THE PHOTOPHORE LENSES OF THE MIDSHIPMAN FISH, PORICHTHYS-NOTATUS GIRARD

      Journal of comparative physiology. A, Sensory, neural, and behavioral physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 21:39:55